Pamela Haley - 16 Aug 2022 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Financial Officer
Signature
Pamela Haley, by Attorney-in-fact, Cesare Suardi
Issuer symbol
RKDA
Transactions as of
16 Aug 2022
Net transactions value
$0
Form type
4
Filing time
18 Aug 2022, 20:56:57 UTC
Previous filing
03 Aug 2022
Next filing
06 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (right to buy) Award $0 +23,000 +9.9% $0.000000 255,313 16 Aug 2022 Common Stock 23,000 $0.9400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in two equal installments occurring on the first, and second anniversary of the date of grant.

Remarks:

None